Results 141 to 150 of about 7,450 (200)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation [PDF]

, 2014

core   +1 more source

The Role of Kidney Biopsy in Fabry Disease. [PDF]

Biomedicines
Capelli I, Martano L, Berti GM, Vischini G, Lerario S, Donadio V, Incensi A, Aiello V, Ciurli F, Fabbrizio B, Chilotti S, Mignani R, Pasquinelli G, La Manna G.   +13 more
europepmc   +1 more source

Fabry Disease Nephropathy: Compendium of "in vitro" and "in vivo" Renal Effects of Globotriaosylsphingosine. [PDF]

Kidney Blood Press Res
Jaurretche SPA, Del Rosal MV, Brajkovic ML, Isaac JI, Venera G, Pérez G.   +5 more
europepmc   +1 more source

Spinal anesthesia in a patient with Fabry disease and multiorgan involvement: a rare case with long-term success. [PDF]

Am J Transl Res
Kim HT, Bae JH, Shin YD, Park JW, Jeong SJ, Lee JY.   +5 more
europepmc   +1 more source

Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression. [PDF]

Int J Mol Sci
Biddeci G, Spinelli G, Colomba P, Duro G, Giacalone I, Di Blasi F.   +5 more
europepmc   +1 more source

Progress and Challenges in the Treatment of Fabry Disease. [PDF]

BioDrugs
Lenders M, Menke ER, Brand E.
europepmc   +1 more source

Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. [PDF]

Sci Rep
Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM.   +4 more
europepmc   +1 more source

Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction. [PDF]

Mol Genet Metab Rep
Inagaki N, Takei Y, Hatano T, Takada Y, Yazaki Y, Kosuge H, Kobayashi M, Suzuki S, Umezu T, Kuroda M, Satomi K, Hayashi T.   +11 more
europepmc   +1 more source

Cellular Lyso-Gb3 Is a Biomarker for Mucolipidosis II. [PDF]

Int J Mol Sci
Terawaki S, Nakanishi H, Shibuya T, Sakai N, Otomo T.   +4 more
europepmc   +1 more source

The role of quantitative cardiovascular MRI and late gadolinium enhancement patterns in differentiating late-onset Anderson-Fabry disease (c.640-801G > A) from hypertrophic cardiomyopathy: a case-control study. [PDF]

Int J Cardiol Heart Vasc
Xu Y, Chen R, Li X, Lin H, Lin L, Lu L, Dai X, Yu Y, Lin Y, Yin L, Ma M.   +10 more
europepmc   +1 more source